Top Markets
#1 Islamic Coin Islamic Coin +152.11%
#2 龙虾 (Lobster) 龙虾 (Lobster) +58.91%
#3 SODAX SODAX +50.51%
#4 Cortex Cortex +32.81%
#5 DexNet DexNet +23.20%
#6 OpenEden OpenEden +20.30%
#7 Pons Pons +19.63%
#8 Akedo Akedo +19.18%
#9 APEX APEX +13.93%
#10 Orbs Orbs +13.24%
Coin of the day
Islamic Coin Islamic Coin
설정
언어
한국어
통화
USD
테마
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
주식 순위 #7324
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
주가
$36.75
마지막 동기화: 2026-08-27
시가총액
$1.63B
변동 (1일)
-0.78%
변동 (1년)
-
국가
US
거래 Avalyn Pharma Inc. Common Stock (AVLN)

카테고리

Healthcare
Avalyn Pharma Inc. Common Stock (AVLN)의 EPS
2026 기준 EPS TTM: 0
Avalyn Pharma Inc. Common Stock의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Avalyn Pharma Inc. Common Stock의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH